These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3959968)

  • 1. Buprenorphine: a new maintenance opiate?
    Seow SS; Quigley AJ; Ilett KF; Dusci LJ; Swensen G; Harrison-Stewart A; Rappeport L
    Med J Aust; 1986 Apr; 144(8):407-11. PubMed ID: 3959968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study.
    Threlkeld M; Parran TV; Adelman CA; Grey SF; Yu J
    Am J Addict; 2006; 15(2):186-91. PubMed ID: 16595358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine suppresses heroin use by heroin addicts.
    Mello NK; Mendelson JH
    Science; 1980 Feb; 207(4431):657-9. PubMed ID: 7352279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
    Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatients.
    Ang-Lee K; Oreskovich MR; Saxon AJ; Jaffe C; Meredith C; Ellis ML; Malte CA; Knox PC
    J Psychoactive Drugs; 2006 Dec; 38(4):505-12. PubMed ID: 17373566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study.
    Tamaskar R; Parran TV; Heggi A; Brateanu A; Rabb M; Yu J
    J Addict Dis; 2003; 22(4):5-12. PubMed ID: 14723474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Benzodiazepine withdrawal in subjects on opiate substitution treatment].
    Fatséas M; Lavie E; Denis C; Franques-Rénéric P; Tignol J; Auriacombe M
    Presse Med; 2006 Apr; 35(4 Pt 1):599-606. PubMed ID: 16614601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment.
    González-Saiz F; Lozano Rojas O; Trujols J; Alcaraz S; Siñol N; Pérez de Los Cobos J;
    Drug Alcohol Depend; 2018 Feb; 183():127-133. PubMed ID: 29247974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction.
    Johnson RE; Cone EJ; Henningfield JE; Fudala PJ
    Clin Pharmacol Ther; 1989 Sep; 46(3):335-43. PubMed ID: 2776393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid heroin detoxification using a single high dose of buprenorphine.
    Kutz I; Reznik V
    J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal.
    Fudala PJ; Jaffe JH; Dax EM; Johnson RE
    Clin Pharmacol Ther; 1990 Apr; 47(4):525-34. PubMed ID: 2328561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine dosing regime in the management of out-patient heroin withdrawal.
    Lintzeris N
    Drug Alcohol Rev; 2002 Mar; 21(1):39-45. PubMed ID: 12189003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.
    Lintzeris N; Bell J; Bammer G; Jolley DJ; Rushworth L
    Addiction; 2002 Nov; 97(11):1395-404. PubMed ID: 12410780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of buprenorphine 24 to 72 hours after dosing.
    Chawarski MC; Schottenfeld RS; O'Connor PG; Pakes J
    Drug Alcohol Depend; 1999 Jun; 55(1-2):157-63. PubMed ID: 10402160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of heroin detoxification with buprenorphine in a psychiatric hospital in Japan.
    Nagano T; Kimoto S; Aso K; Komori T; Yamaguchi Y; Okamura K; Yamamoto N; Kishimoto T
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):376-382. PubMed ID: 33107693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infants of drug-addicted mothers: pitfalls of replacement therapy].
    Vert P; Hamon I; Hubert C; Legagneur M; Hascoet JM
    Bull Acad Natl Med; 2008 May; 192(5):961-9; discussion 969. PubMed ID: 19238786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects.
    De S; Jain R; Ray R; Dhawan A; Varghese ST
    Indian J Physiol Pharmacol; 2008; 52(1):53-63. PubMed ID: 18831352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.